BioAge Labs, Inc. Revenue 2024–2025
BioAge Labs, Inc. annual/quarterly revenue history and growth rate from 2024 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- BioAge Labs, Inc. revenue for the quarter ending March 31, 2026 was 2.8 M, a 91.04% increase year-over-year.
- BioAge Labs, Inc. revenue for the twelve months ending March 31, 2026 was 8.7 M.
- BioAge Labs, Inc. annual revenue for 2025 was 9.0 M.
- BioAge Labs, Inc. annual revenue for 2024 was 0.
BioAge Labs, Inc. (BIOA) — Frequently Asked Questions
BioAge Labs, Inc. (BIOA) is a publicly traded US company. It has a market capitalization of $556M. In fiscal 2025 it reported revenue of $9M and net income of -$81M. Explore BIOA's stock price, financial statements, earnings history, margins and key ratios below.
What is BioAge Labs, Inc.'s market cap?
BioAge Labs, Inc. (BIOA) has a market capitalization of $556M.
What is the BIOA stock price?
BIOA trades at $15.48 (-2.03% on the day).
How much revenue does BioAge Labs, Inc. make?
BioAge Labs, Inc. reported revenue of $9M in fiscal 2025.
Is BIOA profitable?
In fiscal 2025, BioAge Labs, Inc. reported net income of -$81M.